Discover 3,132 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,132
Active & Responsive
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Location: Houston TX, Tampa FL, Omaha NE, Milwaukee WI,
Sponsor: Baylor College of Medicine
Sex: All
Age: 0+
Code: NCT02432625
Recruiting
Active & Responsive
A Study of TAK-505 in Adults With Solid Tumors
for
Malignant Solid Tumors
Location: Houston TX, San Antonio TX, Dallas TX, Nashville TN,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07436728
Phase 1, Phase 2, Recruiting
Active & Responsive
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
for
Type 1 Diabetes, New Onset
Location: Houston TX, Gainesville FL, Indianapolis IN, Miami FL,
Sponsor: City of Hope Medical Center
Sex: All
Age: 9 - 20
Code: NCT07061574
Phase 1, Phase 2, Recruiting
Active & Responsive
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
for
Essential Tremor, Movement Disorders, Essential Tremor,
Location: Houston TX, Memphis TN, Kansas City KS, Louisville KY,
Sponsor: CND Life Sciences
Sex: All
Age: 50 - 70+
Code: NCT07428447
Recruiting
Active & Responsive
EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Houston TX, St Louis MO, Cincinnati OH, Columbus OH,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 70+
Code: NCT06997588
Phase 2, Recruiting
Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country